BioNeex Interviews
BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
LIDDS is a Swedish drug delivery company specializing in depot formulations for intratumoral injections with its NanoZolid te
Mar 28, 2023
Cancer Therapies
AptamiR Therapeutics is a US based preclinical-stage biotech company developing new therapies that target fat accumulation, i
Feb 17, 2023
Cancer Therapies
Oncolyze is a New York based preclinical-stage biotech company developing a class of therapeutics to treat cancer in a new an
Oct 17, 2022
Cancer Therapies
Quivive Pharma is a San Diego-based biotech company developing next generation opioid therapeutics to prevent opioid-induced
Jun 13, 2021
Preclinical Stage
Blue Therapeutics is a Boston based drug discovery and development biotech company. Its disruptive R2i platform technology is
May 24, 2021
CNS